New trials show promise for immune checkpoint blockers in early-stage lung cancer

FHS
April 18, 2024
12:23 pm

A dendritic cell (DC) vaccine targeting patient-specific neoantigens to patients with resected non-small cell lung cancer (NSCLC).

Drug shortages reached a record high as 2023 drew to a close

The number of ongoing and active drug shortages in the U.S. stood at 323 during the fourth quarter of last year — the highest figure

April 11, 2024

RXNT Acquires Scalabull to Streamline EHR Connectivity with Labs and Radiology

What You Should Know: – RXNT, a Maryland-based healthcare technology leader, is continuing its path of accelerated growth with the acquisition of Scalabull, a nationwide

October 3, 2024

Vascular changes in brain trauma could trigger Alzheimer’s development

An increased risk of dementia among individuals exposed to brain trauma, traumatic brain injury, has been known for almost a century.

February 12, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.